secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001824293-24-000007
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio receives second Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------

- Nasdaq letter on Jan 5, 2024: closing bid price below $1.00 for 30 consecutive business days.
- Company has 180 days (until July 3, 2024) to regain compliance; needs $1.00 closing bid for 10 consecutive days.
- Also still non-compliant with stockholders' equity requirement; compliance plan deadline was Jan 6, 2024.
- Special meeting on Jan 19, 2024 to vote on reverse stock split as a potential cure.
- If bid price falls to $0.10 or less for 10 consecutive days, Staff will issue delisting determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000007/0001824293-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000007/val-20240105.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer